aTyr Pharma, Inc.
ATYRNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $16.67M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.17$1.11
- Volume (live)
- -
- Avg. volume (3M)
- 6.18M
aTyr Pharma (ATYR) Stock Price & Financial Analysis
aTyr Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.17 - $0.18 |
|---|---|
| 52-Week High | $1.11 |
| 52-Week Low | $0.17 |
| Open | $0.17 |
| Volume (last close) | 1.04M |
| Average Volume (3M) | 6.18M |
| Revenue (TTM) | 190.00K |
|---|---|
| Net Income (TTM) | -60.81M |
| Free Cash Flow (TTM) | -54.82M |
| EPS (TTM) | −$0.62 |
| Profit Margin | -32003.68% |
| Operating Margin | -33609.47% |
| Return on Equity (ROE) | -124.64% |
| Debt to Equity | 0.23 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 16.67M |
|---|---|
| Shares Outstanding | 98.07M |
| Price to Sales (P/S) | 87.75 |
| Price to Book (P/B) | 0.34 |
| EV/EBITDA | -0.20 |
| 50-Day MA | $0.39 |
|---|---|
| 200-Day MA | $0.63 |
| 1-Year Change | −82.52% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
aTyr Pharma at a Glance
As of the Oct 22, 2026 close, aTyr Pharma (ATYR) has a market capitalization of $16.67M. The stock trades at 87.8× sales. Over the trailing twelve months it lost $60.81M on revenue of $190.00K and burned $54.82M of free cash flow. Revenue fell 19.1% year over year.
As of its latest reported balance sheet, it holds $16.16M in cash and securities against $11.30M of debt, a net cash position of $4.86M.
aTyr Pharma does not currently pay a dividend.
The share price is down 82.5% over the past year. At $0.17 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.17 to $1.11, below its 200-day moving average of $0.63.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $1.00, 488.2% above the Oct 22, 2026 close.
Frequently Asked Questions About aTyr Pharma
What is the current stock price for ATYR?
As of the Oct 22, 2026 close, ATYR stock trades at $0.17. The 52-week range is $0.17–$1.11, with a day range of $0.17–$0.18.
What is the P/E ratio for ATYR?
The P/E ratio (Price-to-Earnings) for ATYR is shown in the Key Statistics section. This valuation metric helps compare aTyr Pharma, Inc. to industry peers.
Does ATYR pay dividends?
aTyr Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ATYR?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for ATYR is Hold. The average 12-month price target is $1.00, a 488.2% upside from the Oct 22, 2026 close of $0.17.
What is the market cap of ATYR?
As of the Oct 22, 2026 close, aTyr Pharma's market capitalization is $16.7M, classifying it as a micro-cap company. aTyr Pharma operates in the Healthcare sector within the Biotechnology industry.